AI Terminal
PROCESSING_QUERY...
Ascelia Pharma
Major Shareholding Notification • Dec 4, 2020
3132_iss_2020-12-04_bda79c33-cf38-4133-8e7a-d483ec2fe9eb.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Issuer Ascelia Pharma AB
Holder
Handelsbanen Fonder AB
Instrument
| Instrument | Aktie SE0010573113 |
|---|---|
| Before the transaction | |
| Shares | 1,416,724 |
| Voting rights | 1,416,724 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 03/12/2020 |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,393,281 |
| Directly held voting rights | 1,393,281 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.86 % |
| Directly held voting rights | 4.93 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|---|---|
| 4.93 % | 1,393,281 |
| 4.93 % | 1,393,281 |
| Email [email protected] |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Ascelia Pharma
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 28
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 28
Share Issue/Capital Change
2025
Nov 19
Share Issue/Capital Change
2025
Nov 19
Quarterly Report
2025
Nov 5
Quarterly Report
2025
Nov 5
Board/Management Information
2025
Nov 3
Board/Management Information
2025
Nov 3
Major Shareholding Notification
2025
Oct 23
Declaration of Voting Results & Voting Rights Announcements
2025
Sep 30